Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

A mixture of anti-CD3 mAb (SPV-T3a)-ricin A chain fusion protein and anti-CD7 mAb (WT1)-ricin A chain fusion protein

EU orphan designation number: EU/3/05/317   
Active ingredient: A mixture of anti-CD3 mAb (SPV-T3a)-ricin A chain fusion protein and anti-CD7 mAb (WT1)-ricin A chain fusion protein
Indication: Treatment of graft-versus-host disease
Sponsor: Xenikos B.V.
Molenveldlaan 168, 6523 RN Nijmegen, Nederlnad

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/08/2005 Orphan designation EMEA/OD/046/05 (2005)3341 of 26/08/2005
12/01/2010 Transfer of orphan designation EMEA/OD/046/05/T/01 (2010)71 of 08/01/2010
30/09/2010 Corrigendum (2010)6815 of 28/09/2010
05/12/2012 Change of name and/or address of sponsor
05/11/2015 Change of name and/or address of sponsor